Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI — Little Rock, Arkansas

Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI is a clinical research site located in Little Rock, Arkansas, United States 72205.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2 Positive Breast Cancer.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Little Rock

Browse all research sites in Arkansas · View every site in Little Rock

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI?

Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI conducted?

Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI has 1 clinical trials on record, with 1 currently active. Their work covers HER2 Positive Breast Cancer.

Is Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI accredited by Crixeo Clinical Trials?

Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Central Arkansas Radiation Therapy Institute Inc d.b.a CARTI?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.